Core Viewpoint - Cronos Group Inc. is set to hold its second quarter earnings conference call on August 7, 2025, at 8:30 a.m. ET, where senior management will discuss financial results and answer questions from the investment community [1]. Group 1 - The conference call will be accessible via online registration, and participants are encouraged to join fifteen minutes early to avoid delays [2]. - Cronos is described as an innovative global cannabinoid company focused on advancing cannabis research, technology, and product development [3]. - The company aims to build a diverse and iconic brand portfolio, which includes brands like Spinach, PEACE NATURALS, and Lord Jones [3].

How did Stiiizy, James Kim’s Los Angeles-based cannabis company, grow from a scrappy startup in 2017 to a legal unicorn worth $1.5 billion? (Photo: Ethan Pines for Forbes)https://t.co/yK39Sc61sG https://t.co/yK39Sc61sG ...

Industry Focus - Cannabis darling Tilray is now high on beer [1]

VANCOUVER, British Columbia, July 24, 2025 (GLOBE NEWSWIRE) -- LEEF Brands, Inc. (CSE: LEEF, OTC: LEEEF) ("LEEF" or the "Company"), a premier California and New York cannabis operator, is pleased to announce a private placement offering (the "Offering") of up to 4,000,000 units of the Company (the “Units”) at a price of C$0.25 per Unit (the "Offering Price"), for gross proceeds of up to C$1,000,000. Each Unit will consist of one common share and one common share purchase warrant (a “Warrant”). Each Warrant ...

Core Insights - Cannara Biotech Inc. has received preliminary acceptance from the Société Québécoise du Cannabis (SQDC) for five vape cartridge products, set to be distributed across all retail stores in Québec starting November 2025 [1][2] - The company aims to leverage its expertise in producing premium live resin vape cartridges, which have no additives, to establish a strong presence in the Québec market [2][4] Company Overview - Cannara Biotech is a vertically integrated producer of premium-grade cannabis products, operating two mega facilities in Québec with a total area of over 1,650,000 sq. ft. and a potential annual cultivation output of 100,000 kg [1][6] - The company focuses on producing affordable premium cannabis products, benefiting from Québec's low electricity costs [6] Market Opportunity - The SQDC reported revenues of $741.5 million for the Québec cannabis market in 2024, indicating significant market potential [3] - A survey revealed that 25% of Québec consumers vaped in the past year, with 28% of those doing so at least weekly, suggesting a growing consumer base for vape products [3] Product Launch - Cannara's entry into the live rosin vape cartridge category represents a significant milestone, utilizing high-quality flower inputs that are grown and extracted in-house [4][5] - The launch is seen as a culmination of extensive research and development efforts, focusing on genetic selection and process refinement [5]

Core Insights - Cannara Biotech Inc. has received preliminary acceptance from the Société Québécoise du Cannabis (SQDC) for five vape cartridge products, set to be distributed across all retail stores in Québec starting November 2025 [1][2] - The company aims to leverage its expertise in producing premium live resin vape cartridges, which have no additives, to establish a strong presence in the Québec market [2][4] Company Developments - Cannara Biotech operates two mega facilities in Québec, totaling over 1,650,000 sq. ft., with a potential annual cultivation output of 100,000 kg [6] - The company has positioned itself as Canada's leading premium live resin vape cartridge provider over the past year, focusing on high-quality formulations [2][4] Market Opportunity - The SQDC reported revenues of $741.5 million for the Québec market in 2024, indicating a significant opportunity for growth in the vape segment, which represents approximately 15% of total sales in other provinces [3] - A survey indicated that 25% of Québec consumers vaped in the past year, with 28% of those doing so at least weekly, highlighting a strong consumer base for vape products [3] Product Launch - Cannara's entry into the live rosin vape cartridge category represents a significant milestone, utilizing high-quality flower inputs that are grown and extracted in-house [4][5] - The launch is seen as a culmination of extensive research and development, focusing on genetic selection and process refinement [5]

Core Viewpoint - Aurora Cannabis Inc. is set to announce its financial results for the first quarter of 2026 on August 6, 2025, and will host a conference call to discuss these results [1][5]. Group 1: Conference Call Details - The conference call is scheduled for August 6, 2025, at 8:00 a.m. Eastern Time and 6:00 a.m. Mountain Time [2]. - Miguel Martin, Executive Chairman and CEO, along with Simona King, CFO, will lead the conference call and Q&A session [2]. Group 2: Company Overview - Aurora Cannabis is a leading global medical cannabis company based in Edmonton, Alberta, serving both medical and consumer markets across Canada, Europe, Australia, and New Zealand [3]. - The company offers a diverse portfolio of brands, including adult-use brands like Drift and San Rafael '71, and medical brands such as MedReleaf and CanniMed [3]. - Aurora holds a controlling interest in Bevo Farms Ltd., a major supplier of propagated agricultural plants in North America [3]. Group 3: Stock Information - Aurora's common shares are traded on NASDAQ and TSX under the symbol "ACB" [4].

In its upcoming report, Tilray Brands, Inc. (TLRY) is predicted by Wall Street analysts to post quarterly loss of -$0.03 per share, reflecting an increase of 25% compared to the same period last year. Revenues are forecasted to be $240.05 million, representing a year-over-year increase of 4.4%. Over the past month, Tilray Brands shares have recorded returns of +105.8% versus the Zacks S&P 500 composite's +5.9% change. Based on its Zacks Rank #3 (Hold), TLRY will likely exhibit a performance that aligns with ...

Core Insights - Trulieve Cannabis Corp. has announced the expanded distribution of its premium Onward beverages and the launch of a new THC-infused energy drink called Upward, available in Florida and Illinois [1][2] - The company has received positive customer feedback for Onward and aims to capitalize on this momentum with the introduction of Upward, which is designed for active and wellness-focused lifestyles [2] - Upward beverages come in various flavors and contain a blend of THC, CBD, and energy-boosting ingredients like green coffee beans and black tea leaves [3] Distribution and Partnerships - Onward and Upward beverages are now available at all ABC Fine Wine & Spirits and Total Wine & More locations in Florida, with new distribution partnerships established with Romano Beverage in Illinois and Anheuser-Busch in Northern Florida [2] - These partnerships will allow the beverages to be found in hundreds of retail locations across Florida and Illinois [2] Product Details - Upward beverages are offered in flavors such as 5 milligram Lemonade, Peach Nectarine, Strawberry Tea, and 10 milligram Pink Lemonade, and are marketed as low-calorie energy drinks [3] - The beverages are crafted in the USA, emphasizing a balance of THC and CBD along with energy-enhancing components [3] Company Overview - Trulieve is a leading vertically integrated cannabis company in the U.S., with significant market presence in Arizona, Florida, and Pennsylvania [5] - The company is focused on growth and expansion through a hub strategy, enhancing retail and distribution capabilities in both new and existing markets [5] - Trulieve aims to provide innovative, high-quality products to improve customer experiences and increase access to cannabis [5]

Core Insights - Greenway Greenhouse Cannabis Corporation reported a significant 71% increase in annual revenue for the year ended March 31, 2025, reaching CAD 8,948,943, with a remarkable 107% growth in the fourth quarter [1][5] - The average selling price of cannabis rose by 40% year-over-year to CAD 1.32 per gram, with the fourth quarter average at CAD 1.46 per gram, indicating strong brand strength and premium product positioning [1][5] - The company transitioned from a cash burn to generating net cash of CAD 1.8 million from operating activities, marking a pivotal shift in financial health [1][5] Financial Performance - The total grams sold during the fiscal year amounted to 6,803,628, reflecting a 23% increase year-over-year [5] - Adjusted EBITDA for the year was CAD 1,181,419, a significant improvement from a negative adjusted EBITDA of CAD 624,391 in the previous year [5][7] - The company achieved a net income of CAD 202,729 in the fourth quarter, showcasing a turnaround in profitability [5] Operational Metrics - The average cash cost per gram sold was CAD 0.83, with a reduced cost of CAD 0.73 in the fourth quarter, indicating improved operational efficiency [5] - Working capital, excluding amounts due to related parties, increased to CAD 3,997,814 as of March 31, 2025, compared to CAD 3,283,911 the previous year [5] - The cash balance rose by CAD 1,612,088 to CAD 3,142,898 over the fiscal year, reflecting enhanced liquidity [5]